Medifast
MED
261 hedge funds and large institutions have $1.96B invested in Medifast in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 74 increasing their positions, 95 reducing their positions, and 31 closing their positions.
71% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 31
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
19% more capital invested
Capital invested by funds: $1.65B → $1.96B (+$311M)
9% more funds holding
Funds holding: 240 → 261 (+21)
4% more call options, than puts
Call options by funds: $50.5M | Put options by funds: $48.4M
0.46% less ownership
Funds ownership: 85.41% → 84.95% (-0.46%)
22% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 95
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$13.9M |
| 2 |
BlackRock
New York
|
+$11.9M |
| 3 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$9.72M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.69M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$7.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
-$44M |
| 2 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$33.8M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$13.4M |
| 4 |
Two Sigma Investments
New York
|
-$6.91M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$6.58M |
MED Hedge Fund Activity: Q4 2020 in Review
261 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2020, worth a combined $1.96B — up 19% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new MED positions and 31 closed out — a net gain of 22 holders — while 74 added to existing stakes and 95 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $13.9M. The largest seller was Engaged Capital, exiting entirely with an estimated $44M sold.
- 261 institutional investors held Medifast (MED) as of Q4 2020, up from 240 in Q3 2020.
- Funds reported $1.96B of Medifast stock for Q4 2020, up 19% quarter-over-quarter.
- 53 funds opened new Medifast positions in Q4 2020 and 31 closed out, a net change of +22 holders.
- The largest Medifast buyer in Q4 2020 was Morgan Stanley, an estimated $13.9M added.
- The largest Medifast seller in Q4 2020 was Engaged Capital, an estimated $44M sold.
Based on aggregated 13F filings for Q4 2020.